Kosnopfel C[Author] - Search Results

Year	Number of Results
2012	1
2013	1
2014	1
2016	1
2017	3
2018	2
2019	1
2020	4
2021	3
2022	3
2023	3
2024	0

1

Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion.

Kosnopfel C, Wendlinger S, Niessner H, Siewert J, Sinnberg T, Hofmann A, Wohlfarth J, Schrama D, Berthold M, Siedel C, Sauer B, Jayanthan A, Lenz G, Dunn SE, Schilling B, Schittek B. Kosnopfel C, et al. J Exp Clin Cancer Res. 2023 Jul 19;42(1):175. doi: 10.1186/s13046-023-02755-5. J Exp Clin Cancer Res. 2023. PMID: 37464364 Free PMC article.

2

mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma.

Xu W, Berning P, Erdmann T, Grau M, Bettazová N, Zapukhlyak M, Frontzek F, Kosnopfel C, Lenz P, Grondine M, Willis B, Lynch JT, Klener P, Hailfinger S, Barry ST, Lenz G. Xu W, et al. Among authors: kosnopfel c. Leukemia. 2023 Jan;37(1):178-189. doi: 10.1038/s41375-022-01749-0. Epub 2022 Nov 9. Leukemia. 2023. PMID: 36352190 Free PMC article.

3

Targeting the Y-box Binding Protein-1 Axis to Overcome Radiochemotherapy Resistance in Solid Tumors.

Lettau K, Khozooei S, Kosnopfel C, Zips D, Schittek B, Toulany M. Lettau K, et al. Among authors: kosnopfel c. Int J Radiat Oncol Biol Phys. 2021 Nov 15;111(4):1072-1087. doi: 10.1016/j.ijrobp.2021.06.021. Epub 2021 Jun 21. Int J Radiat Oncol Biol Phys. 2021. PMID: 34166770 Review.

4

Y-box binding protein 1--a prognostic marker and target in tumour therapy.

Kosnopfel C, Sinnberg T, Schittek B. Kosnopfel C, et al. Eur J Cell Biol. 2014 Jan-Feb;93(1-2):61-70. doi: 10.1016/j.ejcb.2013.11.007. Epub 2013 Dec 27. Eur J Cell Biol. 2014. PMID: 24461929 Review.

5

Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen-activated protein kinase pathway.

Maurus K, Kosnopfel C, Kneitz H, Appenzeller S, Schrama D, Glutsch V, Roth S, Gerhard-Hartmann E, Rosenfeldt M, Möhrmann L, Fröhlich M, Hübschmann D, Stenzinger A, Glimm H, Fröhling S, Goebeler M, Rosenwald A, Kutzner H, Schilling B. Maurus K, et al. Among authors: kosnopfel c. Br J Dermatol. 2022 Mar;186(3):553-563. doi: 10.1111/bjd.20869. Epub 2021 Dec 21. Br J Dermatol. 2022. PMID: 34726260

6

Single-cell trajectories of melanoma cell resistance to targeted treatment.

Schmidt M, Mortensen LS, Loeffler-Wirth H, Kosnopfel C, Krohn K, Binder H, Kunz M. Schmidt M, et al. Among authors: kosnopfel c. Cancer Biol Med. 2021 Oct 1;19(1):56-73. doi: 10.20892/j.issn.2095-3941.2021.0267. Online ahead of print. Cancer Biol Med. 2021. PMID: 34591417 Free PMC article.

7

Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma.

Wendlinger S, Wohlfarth J, Kreft S, Siedel C, Kilian T, Dischinger U, Heppt MV, Wistuba-Hamprecht K, Meier F, Goebeler M, Schadendorf D, Gesierich A, Kosnopfel C, Schilling B. Wendlinger S, et al. Among authors: kosnopfel c. Cancers (Basel). 2022 May 4;14(9):2294. doi: 10.3390/cancers14092294. Cancers (Basel). 2022. PMID: 35565423 Free PMC article.

8

Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and Invasion.

Kosnopfel C, Sinnberg T, Sauer B, Niessner H, Muenchow A, Fehrenbacher B, Schaller M, Mertens PR, Garbe C, Thakur BK, Schittek B. Kosnopfel C, et al. Cancers (Basel). 2020 Aug 18;12(8):2328. doi: 10.3390/cancers12082328. Cancers (Basel). 2020. PMID: 32824741 Free PMC article.

9

Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition.

Makino E, Fröhlich LM, Sinnberg T, Kosnopfel C, Sauer B, Garbe C, Schittek B. Makino E, et al. Among authors: kosnopfel c. Cell Death Dis. 2020 Jul 2;11(7):581. doi: 10.1038/s41419-020-2702-y. Cell Death Dis. 2020. PMID: 32719412 Free PMC article.

10

Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma.

Niessner H, Hüsch A, Kosnopfel C, Meinhardt M, Westphal D, Meier F, Schilling B, Sinnberg T. Niessner H, et al. Among authors: kosnopfel c. Cancers (Basel). 2023 Nov 22;15(23):5521. doi: 10.3390/cancers15235521. Cancers (Basel). 2023. PMID: 38067230 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year